NovaBone is introducing its Bioactive Pre-contoured Wedge (BPW), the first fully synthetic, porous bioactive glass solution specifically designed for osteostimulation.
BPW is the first non-metal wedge that is classified as a device, prioritizing patient safety and intra-operative effectiveness. It is engineered to correct deformities and fill osseous defects, while providing a fully resorbable, bio-integrative scaffold that promotes and accelerates bone regeneration.
Key benefits of the NovaBone Bioactive Pre-contoured Wedge include:
First-to-market bioactive pre-contoured wedge, regulated as a Class II device
Bioactive glass structure that claims both osteoconductivity and osteostimulation
Fully resorbable and replaced by native bone, obviating implant removal
More cost-effective than metal implants, with a five-year shelf life
Compatible with reconstructive plating and staple solutions
“NovaBone’s Bioactive Pre-contoured Wedge is an innovative solution for orthopedic and podiatric surgeons, leveraging our superiority in BioGlass manufacturing,” said Scott Day, Vice President of Marketing & Business Development at NovaBone. “This new wedge provides an efficacious and affordable alternative to metal. Additionally, because the wedges are manufactured in the USA and have a 5-year shelf life, they are easy to stock, which reduces reliance on vulnerable global supply chains, limits tariff exposure, and eliminates problematic lead times.”
NovaBone is introducing its Bioactive Pre-contoured Wedge (BPW), the first fully synthetic, porous bioactive glass solution specifically designed for osteostimulation.
BPW is the first non-metal wedge that is classified as a device, prioritizing patient safety and intra-operative effectiveness. It is engineered to correct deformities and fill...
NovaBone is introducing its Bioactive Pre-contoured Wedge (BPW), the first fully synthetic, porous bioactive glass solution specifically designed for osteostimulation.
BPW is the first non-metal wedge that is classified as a device, prioritizing patient safety and intra-operative effectiveness. It is engineered to correct deformities and fill osseous defects, while providing a fully resorbable, bio-integrative scaffold that promotes and accelerates bone regeneration.
Key benefits of the NovaBone Bioactive Pre-contoured Wedge include:
First-to-market bioactive pre-contoured wedge, regulated as a Class II device
Bioactive glass structure that claims both osteoconductivity and osteostimulation
Fully resorbable and replaced by native bone, obviating implant removal
More cost-effective than metal implants, with a five-year shelf life
Compatible with reconstructive plating and staple solutions
“NovaBone’s Bioactive Pre-contoured Wedge is an innovative solution for orthopedic and podiatric surgeons, leveraging our superiority in BioGlass manufacturing,” said Scott Day, Vice President of Marketing & Business Development at NovaBone. “This new wedge provides an efficacious and affordable alternative to metal. Additionally, because the wedges are manufactured in the USA and have a 5-year shelf life, they are easy to stock, which reduces reliance on vulnerable global supply chains, limits tariff exposure, and eliminates problematic lead times.”
Copy to clipboard 
